logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

A KRW 16 trillion big red envelope! SK Hynix (SKHY.US) plans to "generously distribute" 80% of gains from its Kioxia stake to shareholders.

date
26/10/2026
Zhitong Finance APP has learned that, according to reports, SK Hynix (SKHY.US) plans to return about 80% of the proceeds from reducing its stake in Japan's Kioxia Holdings to shareholders through a special dividend of approximately KRW 16 trillion (about USD 12 billion).
Latest
3 m ago
Institution: Samsung Electronics and SK Hynix valuations have fallen to levels last seen during the financial crisis
3 m ago
Orient Securities: Equity market pullback drags on investment returns, listed insurers face pressure on Q3 profits
3 m ago
Hong Kong Stock Movement | Realord Group Holdings Limited (01196.HK) surged over 10% in morning trading; shares trading under stock code 1196 remain eligible for Stock Connect trading.
4 m ago
Liangjing Technology Completes Multiple Rounds of Financing Totaling Hundreds of Millions of Yuan
4 m ago
Hong Kong Stock Movement | CStone Pharmaceuticals-B (02616.HK) Rises Nearly 7% in Early Trading as CS2009 Achieves Major Clinical Validation Milestone and Is Announced at ESMO 2026
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.